Fluoroquinolones and isoniazid resistant TB: implications for the 2018 WHO guidance von Stagg, HR, Bothamley, GH, Davidson, JA, Kunst, H, Lalor, MK, Lipman, MC, Loutet, MG, Lozewicz, S, Mohiyuddin, T, Abbara, A, Alexander, E, Booth, H, Creer, DD, Harris, RJ, Kon, OM, Loebinger, MR, McHugh, TD, Milburn, HJ, Palchaudhuri, P, Phillips, PPJ, Schmok, E, Taylor, L, Abubakar, I, Baker, LV, Barrett, JC, Burgess, H, Cosgrove, C, Dunleavy, A, Francis, M, Gupta, U, Hamid, S, Haselden, BM, Holden, E, Kahr, V, Lynn, W, Perrin, FM, Rahman, A, Soobratty, MR, London INH-R TB study group

Volltext bestellen